Evidence map›Paper›PMID 27159970›Full record

ArticleBMC microbiology2016

Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.

Verena Hoerr, Gavin E Duggan, Lori Zbytnuik, Karen K H Poon, Christina Große, Ute Neugebauer, Karen Methling, Bettina Löffler, Hans J Vogel

Abstract read
In one paragraph

Article in BMC microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. QuantitativeMolecules (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. The ability ofFrontiers in plant science · 2024
    Article
  12. Article
  13. Natural Products Drug Discovery: On Silica or In-Silico?Handbook of experimental pharmacology · 2023
    Article
  14. Risk Factors of Clonally Related, Multi, and Extensively Drug-ResistantThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2023
    Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Metabolomic Profiles of Multidrug-ResistantAnimals : an open access journal from MDPI · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Verena HoerrInstitute of Medical Microbiology, Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany. verena.hoerr@uni-jena.de.
Gavin E DugganBiochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, Canada.
Lori ZbytnuikDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Canada.
Karen K H PoonDepartment of Physiology and Pharmacology, University of Calgary, Calgary, Canada.
Christina GroßeCenter for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Ute NeugebauerCenter for Sepsis Control and Care, Jena University Hospital, Jena, Germany.
Karen MethlingInstitute of Biochemistry, University of Greifswald, Greifswald, Germany.
Bettina LöfflerInstitute of Medical Microbiology, Jena University Hospital, Erlanger Allee 101, D-07747, Jena, Germany.
Hans J VogelBiochemistry Research Group, Department of Biological Sciences, University of Calgary, Calgary, Canada.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundThe emergence of antibiotic resistant pathogenic bacteria has reduced our ability to combat infectious diseases. At the same time the numbers of new antibiotics reaching the market have decreased. This situation has created an urgent need to discover novel antibiotic scaffolds. Recently, the application of pattern recognition techniques to identify molecular fingerprints in 'omics' studies, has emerged as an important tool in biomedical research and laboratory medicine to identify pathogens, to monitor therapeutic treatments or to develop drugs with improved metabolic stability, toxicological profile and efficacy. Here, we hypothesize that a combination of metabolic intracellular fingerprints and extracellular footprints would provide a more comprehensive picture about the mechanism of action of novel antibiotics in drug discovery programs.

resultsIn an attempt to integrate the metabolomics approach as a classification tool in the drug discovery processes, we have used quantitative (1)H NMR spectroscopy to study the metabolic response of Escherichia coli cultures to different antibiotics. Within the frame of our study the effects of five different and well-known antibiotic classes on the bacterial metabolome were investigated both by intracellular fingerprint and extracellular footprint analysis. The metabolic fingerprints and footprints of bacterial cultures were affected in a distinct manner and provided complementary information regarding intracellular and extracellular targets such as protein synthesis, DNA and cell wall. While cell cultures affected by antibiotics that act on intracellular targets showed class-specific fingerprints, the metabolic footprints differed significantly only when antibiotics that target the cell wall were applied. In addition, using a training set of E. coli fingerprints extracted after treatment with different antibiotic classes, the mode of action of streptomycin, tetracycline and carbenicillin could be correctly predicted.

conclusionThe metabolic profiles of E. coli treated with antibiotics with intracellular and extracellular targets could be separated in fingerprint and footprint analysis, respectively and provided complementary information. Based on the specific fingerprints obtained for different classes of antibiotics, the mode of action of several antibiotics could be predicted. The same classification approach should be applicable to studies of other pathogenic bacteria.

Indexed as

Anti-Bacterial AgentsCarbenicillinDrug DiscoveryEscherichia coliMetabolomicsMicrobial Sensitivity TestsMultivariate AnalysisPilot ProjectsProton Magnetic Resonance SpectroscopyStreptomycinTetracyclineAnti-Bacterial AgentsCarbenicillinStreptomycinTetracycline1H NMR spectroscopyExtracellular footprintingIntracellular fingerprintingMetabolomicsMode of action of antibioticsMultivariate data analysisPrediction of antibiotic classes

Identifiers

PMID27159970
PMCPMC4862084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.